A nurse is assessing a client who received hydromorphone 4 mg IV 15 min ago. The client has a respiratory rate of 10/min. The nurse should prepare to administer which of the following medications?

A) Flumazenil: Flumazenil is a benzodiazepine antagonist used to reverse the effects of benzodiazepine overdose. Since the client received hydromorphone, which is an opioid, flumazenil would not be the appropriate medication to administer in this situation. The respiratory depression is likely due to opioid use, so this option does not address the client’s specific needs. B) Protamine: Protamine is a medication used to reverse the effects of heparin, an anticoagulant. It is not indicated for opioid overdose or respiratory depression caused by opioids. Therefore, administering protamine would not be relevant in this scenario and would not help address the client's low respiratory rate. C) Acetylcysteine: Acetylcysteine is primarily used as an antidote for acetaminophen overdose and to help loosen mucus in conditions like cystic fibrosis. It does not have a role in reversing opioid effects. The client’s respiratory depression following hydromorphone administration would not be treated with acetylcysteine. D) Naloxone: Naloxone is an opioid antagonist specifically designed to reverse the effects of opioid medications, including respiratory depression. Given that the client is experiencing a significantly low respiratory rate of 10/min after receiving hydromorphone, naloxone is the most appropriate medication to administer promptly to restore normal respiratory function.